RecruitingNot ApplicableNCT07019259

Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors

Sponsor

Yale University

Enrollment

20 participants

Start Date

Jun 30, 2025

Study Type

INTERVENTIONAL

Conditions

Chemotherapy Induced Peripheral Neuropathy Cancer Childhood Cancer

Summary

The purpose of this study is to determine feasibility and acceptability of a six-week at-home light therapy protocol in childhood cancer survivors, to identify facilitators and barriers to implementing this intervention, and to measure signs and symptoms of Chemotherapy Induced Peripheral Neuropathy (CIPN) at baseline and following completion of the at-home light therapy protocol.

Eligibility

Min Age: 5 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Anodyne Therapy System for people with cancer, chemotherapy induced peripheral neuropathy, and other related conditions. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 5 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEAnodyne Therapy System

Survivors will be provided the Anodyne Therapy System Model 120 to use as part of a 6-week at-home light therapy intervention. Participants will be instructed on where apply the device based on location of their symptoms, and will be instructed to use the device for 15 minutes per day, 3 days per week. Proper use of the device will be demonstrated in clinic by a trained physical therapist or study team member.